OCTIMET Oncology
Description: OCTIMET Oncology develops OMO-1, a MET kinase inhibitor for cancer, partnering with Allist Pharma for China and DeuterOncology globally.
Country: Belgium
Based in: Beerse
Founded: 2016
Funding Stage: Series A/B
Tags: ['Biotechnology', 'Medical']
ACCESS DIRECTORY
Details about how we process your information are available in our Privacy Policy.
